Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
FTH

Faeth Therapeutics (FTH) stock: insider trades, news & valuation

Strong buying
Close · Oct 9, 2026 $26.03 +1.6% on the day +124.6% over 12 months 52-week range $7.89 – $40.05

Share price and insider trades

FTH closeInsider buyInsider sale
01020304050NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $13,540 on 2026-03-27 · Ics Opportunities Ii LlcBought $19,396 on 2026-06-29 · Brian C StephensonSold $23,632 on 2026-03-30 · Ics Opportunities Ii LlcSold $26,672 on 2025-12-08 · James PeyerBought $34,246 on 2026-04-06 · Ics Opportunities Ii LlcSold $36,397 on 2026-04-01 · Millennium Management LlcBought $36,985 on 2026-04-07 · Ics Opportunities Ii LlcSold $39,096 on 2026-04-06 · Ics Opportunities Ii LlcSold $40,555 on 2026-03-31 · Millennium Management LlcSold $52,222 on 2026-03-26 · Ics Opportunities Ii LlcBought $70,132 on 2026-04-02 · Ics Opportunities Ii LlcSold $82,478 on 2025-12-09 · Cambrian Biopharma Inc, James PeyerSold $90,600 on 2025-12-04 · Cambrian Biopharma Inc, James PeyerBought $117,492 on 2026-07-01 · Brian C StephensonBought $155,908 on 2026-06-26 · Brian C StephensonBought $164,043 on 2026-03-26 · Ics Opportunities Ii LlcBought $169,126 on 2026-03-31 · Millennium Management LlcBought $189,240 on 2026-06-30 · Brian C StephensonBought $212,999 on 2026-04-01 · Millennium Management LlcBought $224,806 on 2026-06-23 · Brian C StephensonBought $236,561 on 2026-06-22 · Anand Kiran Parikh, Brian C StephensonBought $245,360 on 2026-06-24 · Brian C StephensonSold $246,219 on 2026-04-02 · Ics Opportunities Ii LlcBought $246,500 on 2026-03-30 · Ics Opportunities Ii LlcSold $252,752 on 2026-04-07 · Ics Opportunities Ii LlcSold $374,780 on 2025-12-05 · Cambrian Biopharma Inc, James PeyerBought $407,670 on 2026-03-27 · Ics Opportunities Ii LlcSold $1,001,085 on 2026-06-01 · Cambrian Biopharma Inc, James Peyer
Bought, 12 months$2.5M
Sold, 12 months$2.3M
Insiders buying4
Insiders selling4

Faeth Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $2.5M and 4 sold $2.3M of FTH stock on the open market.

FTH insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $575K sold (16 trades)Q4 2025Q1 2026: $987K bought (18 trades)$987KQ1 2026: $130K sold (11 trades)Q1 2026Q2 2026: $1.4M bought (29 trades)$1.4MQ2 2026: $1.6M sold (18 trades)Q2 2026Q3 2026: $117K bought (2 trades)$117KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$117K2—0
Q2 2026$1.4M29$1.6M18
Q1 2026$987K18$130K11
Q4 2025—0$575K16

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit−$19KOn all tracked purchases -0.8%

Summary

Over the past 12 months, 4 Faeth Therapeutics, Inc. insiders reported open-market purchases totaling $2.5M, while 4 insiders reported sales totaling $2.3M. Among insiders with enough purchase history to measure, Ics Opportunities Ii Llc (10% Owner) has the highest Insider Score at 91. 0 of 45 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 1SEC Brian C StephensonCFO Buy 4,25541,688 held (+11%) $24.98 $106K +4.2% 87
Jul 1SEC Brian C StephensonCFO Buy 4,40046,088 held (+11%) $23.40 $103K +11.2% 87
Jul 1SEC Brian C StephensonCFO Buy 1,91035,795 held (+6%) $22.95 $44K +13.4% 87
Jul 1SEC Brian C StephensonCFO Buy 1,63837,433 held (+5%) $23.88 $39K +9.0% 87
Jul 1SEC Brian C StephensonCFO Buy 83133,885 held (+3%) $23.34 $19K +11.5% 87
Jul 1SEC Brian C StephensonCFO Buy 60046,688 held (+1%) $24.22 $15K +7.5% 87
Jun 26SEC Brian C StephensonCFO Buy 4,21231,596 held (+15%) $24.90 $105K +4.5% 87
Jun 26SEC Brian C StephensonCFO Buy 3,40026,704 held (+15%) $26.98 $92K -3.5% 87
Jun 26SEC Brian C StephensonCFO Buy 3,00023,304 held (+15%) $25.98 $78K +0.2% 87
Jun 26SEC Brian C StephensonCFO Buy 2,89120,304 held (+17%) $25.22 $73K +3.2% 87
Jun 26SEC Brian C StephensonCFO Buy 1,35832,954 held (+4%) $25.55 $35K +1.9% 87
Jun 26SEC Brian C StephensonCFO Buy 58027,384 held (+2%) $23.61 $14K +10.2% 87
Jun 26SEC Brian C StephensonCFO Buy 10026,804 held (+0%) $27.77 $3K -6.3% 87
Jun 26SEC Brian C StephensonCFO Buy 10033,054 held (+0%) $26.39 $3K -1.4% 87
Jun 24SEC Brian C StephensonCFO Buy 6,83615,019 held (+84%) $24.12 $165K +7.9% 87
Jun 24SEC Brian C StephensonCFO Buy 3,3297,827 held (+74%) $23.28 $77K +11.8% 87
Jun 24SEC Anand Kiran ParikhCEO, President Buy 2,806764,234 held (+0%) $19.76 $55K +31.7% —
Jun 24SEC Brian C StephensonCFO Buy 1,96916,988 held (+13%) $24.84 $49K +4.8% 87
Jun 24SEC Brian C StephensonCFO Buy 1,797new position $20.23 $36K +28.7% 87
Jun 24SEC Brian C StephensonCFO Buy 1,5834,498 held (+54%) $22.40 $35K +16.2% 87
Jun 24SEC Brian C StephensonCFO Buy 1,1182,915 held (+62%) $20.82 $23K +25.0% 87
Jun 24SEC Brian C StephensonCFO Buy 42517,413 held (+3%) $25.91 $11K +0.5% 87
Jun 24SEC Brian C StephensonCFO Buy 3568,183 held (+5%) $23.95 $9K +8.7% 87
Jun 1SEC Cambrian Biopharma Inc10% Owner Sell 24,524130,618 held (−16%) $20.00 $490K +30.2% —
Jun 1SEC James PeyerSee Remarks Below Sell 24,524130,618 held (−16%) $20.00 $490K +30.2% —
Jun 1SEC Cambrian Biopharma Inc10% Owner Sell 476130,142 held (−0%) $21.14 $10K +23.1% —
Jun 1SEC James PeyerSee Remarks Below Sell 476130,142 held (−0%) $21.14 $10K +23.1% —
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 10,643142,360 held (+8%) $26.29 $280K -1.0% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 4,423133,986 held (−3%) $31.38 $139K -17.0% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 4,995145,678 held (+4%) $25.99 $130K +0.2% 91
May 15SEC Millennium Management Llc10% Owner Buy 3,401147,731 held (+2%) $35.46 $121K -26.6% —
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 4,384142,360 held (+3%) $27.28 $120K -4.6% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 3,099144,974 held (−2%) $30.86 $96K -15.7% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 2,992145,678 held (+2%) $25.08 $75K +3.8% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 2,601131,370 held (+2%) $28.85 $75K -9.8% 91
May 15SEC Millennium Management Llc10% Owner Buy 1,957146,657 held (+1%) $31.45 $62K -17.2% —
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 2,115133,986 held (−2%) $28.94 $61K -10.1% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 1,794144,974 held (−1%) $32.60 $58K -20.2% 91
May 15SEC Millennium Management Llc10% Owner Buy 1,613147,731 held (+1%) $34.59 $56K -24.7% —
May 15SEC Millennium Management Llc10% Owner Buy 1,770146,657 held (+1%) $25.32 $45K +2.8% —
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 1,276144,974 held (+1%) $34.75 $44K -25.1% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 1,265144,974 held (−1%) $31.75 $40K -18.0% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 1,134144,974 held (−1%) $34.80 $39K -25.2% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 1,214141,029 held (−1%) $31.02 $38K -16.1% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 1,327131,370 held (+1%) $27.95 $37K -6.9% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 1,108133,986 held (+1%) $33.38 $37K -22.0% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 1,108133,986 held (−1%) $33.38 $37K -22.0% 91
May 15SEC Millennium Management Llc10% Owner Buy 1,161147,731 held (+1%) $31.53 $37K -17.4% —
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 1,274131,370 held (−1%) $28.69 $37K -9.3% 91
May 15SEC Millennium Management Llc10% Owner Sell 1,104147,731 held (−1%) $31.52 $35K -17.4% —
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 1,104141,029 held (+1%) $31.02 $34K -16.1% 91
May 15SEC Millennium Management Llc10% Owner Sell 1,251146,657 held (−1%) $25.17 $31K +3.4% —
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 1,176145,678 held (+1%) $26.70 $31K -2.5% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 1,025131,370 held (+1%) $29.98 $31K -13.2% 91
May 15SEC Millennium Management Llc10% Owner Buy 1,048146,657 held (+1%) $26.73 $28K -2.6% —
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 701144,974 held (+0%) $35.55 $25K -26.8% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 778131,370 held (+1%) $27.23 $21K -4.4% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 583131,370 held (−0%) $26.88 $16K -3.2% 91
May 15SEC Millennium Management Llc10% Owner Buy 616146,657 held (+0%) $24.69 $15K +5.4% —
May 15SEC Millennium Management Llc10% Owner Buy 411146,657 held (+0%) $32.60 $13K -20.2% —
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 518145,678 held (−0%) $25.85 $13K +0.7% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 469142,360 held (−0%) $26.77 $13K -2.8% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 374144,974 held (−0%) $33.35 $12K -21.9% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 370145,678 held (+0%) $27.68 $10K -6.0% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 370145,678 held (−0%) $27.68 $10K -6.0% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 300133,986 held (−0%) $32.25 $10K -19.3% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 294142,360 held (+0%) $28.13 $8K -7.5% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 205133,986 held (−0%) $29.71 $6K -12.4% 91
May 15SEC Millennium Management Llc10% Owner Buy 186146,657 held (+0%) $30.48 $6K -14.6% —
May 15SEC Millennium Management Llc10% Owner Sell 191146,657 held (−0%) $24.28 $5K +7.2% —
May 15SEC Millennium Management Llc10% Owner Sell 87146,657 held (−0%) $31.52 $3K -17.4% —
May 15SEC Millennium Management Llc10% Owner Sell 46147,731 held (−0%) $34.75 $2K -25.1% —
May 15SEC Millennium Management Llc10% Owner Sell 57146,657 held (−0%) $27.11 $2K -4.0% —
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 45141,029 held (−0%) $31.96 $1K -18.6% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Sell 36142,360 held (−0%) $27.37 $985 -4.9% 91
May 15SEC Ics Opportunities Ii Llc10% Owner Buy 26144,974 held (+0%) $33.47 $870 -22.2% 91
May 15SEC Millennium Management Llc10% Owner Buy 17146,657 held (+0%) $27.78 $472 -6.3% —
May 15SEC Millennium Management Llc10% Owner Sell 5146,657 held (−0%) $28.41 $142 -8.4% —
Dec 10SEC Cambrian Biopharma Inc10% Owner Sell 3,105158,254 held (−2%) $8.59 $27K +203.0% —
Dec 10SEC James PeyerSee Remarks Below Sell 3,105158,254 held (−2%) $8.59 $27K +203.0% —
Dec 10SEC Cambrian Biopharma Inc10% Owner Sell 2,666155,588 held (−2%) $7.95 $21K +227.4% —
Dec 10SEC James PeyerSee Remarks Below Sell 2,666155,588 held (−2%) $7.95 $21K +227.4% —
Dec 10SEC Cambrian Biopharma Inc10% Owner Sell 446155,142 held (−0%) $7.92 $4K +228.7% —
Dec 10SEC James PeyerSee Remarks Below Sell 446155,142 held (−0%) $7.92 $4K +228.7% —
Dec 10SEC Cambrian Biopharma Inc10% Owner Sell 395155,588 held (−0%) $8.04 $3K +223.8% —
Dec 10SEC James PeyerSee Remarks Below Sell 395155,588 held (−0%) $8.04 $3K +223.8% —
Dec 8SEC James PeyerSee Remarks Below Sell 14,508163,146 held (−8%) $11.40 $165K +128.3% —
Dec 8SEC Cambrian Biopharma Inc10% Owner Sell 14,508163,146 held (−8%) $11.40 $165K +128.3% —
Dec 8SEC James PeyerSee Remarks Below Sell 5,000177,654 held (−3%) $9.06 $45K +187.3% —
Dec 8SEC Cambrian Biopharma Inc10% Owner Sell 5,000177,654 held (−3%) $9.06 $45K +187.3% —
Dec 8SEC James PeyerSee Remarks Below Sell 1,745161,401 held (−1%) $12.29 $21K +111.8% —
Dec 8SEC Cambrian Biopharma Inc10% Owner Sell 1,745161,401 held (−1%) $12.29 $21K +111.8% —
Dec 8SEC James PeyerSee Remarks Below Sell 42161,359 held (−0%) $13.16 $553 +97.8% —
Dec 8SEC Cambrian Biopharma Inc10% Owner Sell 42161,359 held (−0%) $13.16 $553 +97.8% —

Insiders at Faeth Therapeutics, Inc.

InsiderBoughtSoldLast filingScore
Ics Opportunities Ii Llc10% Owner $960K $627K May 15, 2026 91
Brian C StephensonCFO $1.1M — Jul 1, 2026 87
Millennium Management Llc10% Owner $382K $77K May 15, 2026 —
Cambrian Biopharma Inc10% Owner — $788K Jun 1, 2026 —
James PeyerSee Remarks Below — $788K Jun 1, 2026 —
Anand Kiran ParikhCEO, President $55K — Jun 24, 2026 —

FTH stock: common questions

Are Faeth Therapeutics, Inc. insiders buying FTH stock?

In the past 12 months, 4 insiders reported open-market purchases of FTH worth $2.5M. The latest was CFO Brian C Stephenson bought $106K of FTH at $24.98.

Are Faeth Therapeutics, Inc. insiders selling FTH stock?

4 insiders reported sales worth $2.3M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is FTH's 52-week range?

Over the past year FTH has traded between $7.89 and $40.05. It last closed at $26.03 on Oct 9, 2026.